FAPI pet scan for cancer and other diseases
Part of Blood & lymphatic, Cancer, Digestive system, Heart & circulation, Hormones & metabolism, Immune system & allergy, Kidney & urinary, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This trial uses a special PET scan to look at diseases like cancer. It aims to see if this new imaging method can help doctors find or monitor disease better. This could be helpful for people with confirmed or suspected cancer or other conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You should have a known or suspected cancer or another medical condition that needs imaging.
- You need to have had standard imaging like a CT, MRI, or regular PET scan before.
- You must be able to lie still for the scan and not be severely claustrophobic.
- You cannot be pregnant or breastfeeding.
- You must not have had an allergic reaction to a radiotracer before.
- If you will have a combined PET/MRI scan, you must not have metal implants like a pacemaker or cochlear implant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging agent (18F-FAPI-04) for PET scans to see if it can better detect breast cancer or its spread. It may help doctors find tumors more clearly.
This trial tests a new imaging agent, [18F]FAPI-74, which might help detect certain cancers more clearly. The scan looks for a protein called fibroblast activation protein (FAP) that is often found in tumors. If you have one of the listed cancers and are about to start treatment, this study could help doctors see where the cancer is and how it responds to therapy.
This trial tests a new imaging agent (18F-FAPI) to see if it can help find tumors early in people with lung, thyroid, pancreatic, melanoma, or neuroendocrine cancers.
This trial tests whether a special PET/CT scan using a tracer called FAPI can better detect if breast cancer has spread to lymph nodes under the arm after neoadjuvant treatment. If successful, it could guide more precise surgery and avoid unnecessary lymph node removal.
This trial tests a new PET scan drug (18F-FAPI) to see if it can better detect where stomach or esophageal cancer has spread. It may help doctors plan the right treatment for you.
This study uses a new type of PET scan (called FAPI) to better see if cancer has spread to lymph nodes or other parts of the body. It may help your doctor plan the right treatment without needing invasive tests.
Hear when a new Head and Neck Cancer (H&N) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.